Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined cystatin C and creatinine based estimated glomerular filtration rate for colistin dosing on prevention of acute kidney injury
TCTR20240605006Phase 3Not yet recruiting
- Sponsor
- Excellence Center for Critical Care Nephrology
- Start
- Aug 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of colistin in acute kidney failure (AKF), sponsored by Excellence Center for Critical Care Nephrology. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
colistin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on TCTR20240605006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240605006.